Hematopoietic potential arises in mammalian embryos before adult-repopulating hematopoietic stem cells (HSCs). At E9.5, we show the first murine definitive erythro-myeloid progenitors (EMPs) have an immunophenotype distinct from primitive hematopoietic progenitors, maturing megakaryocytes and macrophages, and rare B cell potential. EMPs emerge in the yolk sac with erythroid and broad myeloid, but not lymphoid, potential. EMPs migrate to the fetal liver and rapidly differentiate including production of circulating neutrophils by E11.5. While the surface markers, transcription factors and lineage potential associated with EMPs overlap with those found in adult definitive hematopoiesis, they are present in unique combinations or proportions that result in a specialized definitive embryonic progenitor. Further, we find that ES cell -derived hematopoiesis recapitulates early yolk sac hematopoiesis, including primitive, EMP and rare B cell potential. EMPs do not have long term potential when transplanted in immunocompromised adults, but can provide transient adult-like RBC reconstitution.
Introduction
Hematopoiesis in the adult consists of multipotent hematopoietic stem cells (HSCs) that differentiate through increasingly lineage-restricted progenitors that are modulated to provide a plethora of mature blood cells. However, this paradigm does not hold for the early embryo, which must simultaneously create the hematopoietic system while meeting the demands of embryonic growth and tissue differentiation with expanding blood cell numbers and lineage complexity. Additionally, hematopoietic function is required prior to the Contact Information: James Palis at james_palis@urmc.rochester.edu. Author Contributions K.E.M, J.M.F, K.H.F., J.R.B., S.C.C., P.D.K. A.D.K. and J.P. performed experiments and analyzed data. S.J.C. provided founder mice for NCX1 knock-out colony. K.E.M designed experiments and wrote the manuscript with assistance from J.P. and J.M.F. (Fig. 1A) . By E8.5, concurrent with the appearance of the first definitive hematopoietic colony-forming cells (CFCs), a small population of kit hi CD41 + cells is detected in the yolk sac. A subset of E8.5 kit hi CD41 + cells is also positive for CD16/32, an antibody that recognizes the low affinity FCγII/III receptors (Fig. 1A) . Both CD16/32− positive andnegative cell fractions contain definitive hematopoietic CFC activity, as defined by definitive erythroid or granulocyte potential, which are not contained in the primitive wave of hematopoiesis (Fig. 1B , Palis et al., 1999) . At E8.5, primitive erythroid CFCs were localized to the kit lo CD41 lo population, while macrophage potential, a component of both primitive and EMP hematopoietic waves, was present in kit lo and kit hi populations. By E9.5, the kit + CD41 + population increased to more than one thousand cells per yolk sac, over 90% of which are CD16/32 + (Fig. 1A) . At E9.5, we found that the erythroid, megakaryocyte and myeloid CFCs, including high proliferative potential progenitors (HPP-CFCs), were associated with the kit + CD41 + CD16/32 + population (Fig. 1C) . Thus, definitive EMP potential arises at E8.25 as a kit hi CD41 + population and by E9.5, resides in a kit hi CD41 + CD16/32 + population.
E9.5 yolk sacs also contain hundreds of kit-negative cells expressing either CD41 or CD16/32 (Fig. 1D ) that lack CFC potential (Fig. 1C) , but express other cell surface markers consistent with maturing megakaryocytes (GP1bβ + CD45 − ) or macrophages (F4/80 + CD45 + ), respectively (Fig. 1D ). The lineage markers GP1bβ or F4/80 were not expressed on the kit hi EMPs. The presence of hundreds of maturing megakaryocytes and macrophages at E9.5, when only a few EMPs are detected one day earlier, is consistent with their derivation from the hundreds of primitive hematopoietic progenitors that emerge in the yolk sac between E7.25 and E8.5. Taken together, our data indicate that by E9.5, the murine yolk sac contains several distinct populations of blood cells, which include maturing primitive erythroblasts, megakaryocytes, and macrophages, as well as an emerging population of definitive hematopoietic progenitors, EMPs, identified by their concurrent surface expression of kit, CD41 and CD16/32.
EMPs emerge in the yolk sac
Definitive hematopoietic progenitors are found in the embryo proper only after the onset of circulation (E8.25), and circulation-deficient mouse embryos lack definitive CFC in the embryo proper at E9.5 (Lux et al., 2008; Palis et al., 1999) . However, other vascular beds, including the forming placenta and vitelline and umbilical vessels, have also been suggested as sites of early hematopoietic progenitor emergence (de Bruijn et al., 2000; GordonKeylock et al., 2013) . Therefore, we reassessed the spatial and temporal emergence of EMPs in the total conceptus, using the presence of primitive erythroblasts (EryP) to estimate the contribution of yolk sac-derived blood cells found circulating in tissues (McGrath et al., 2003) . At E9.5, immunophenotypic EMPs were enriched in the yolk sac, but not in the placenta or in extraembryonic vessels compared to the embryo proper (Fig. 1E) . Additionally, EMPs emerged from cultured yolk sacs, but not chorion, allantois or embryo propers from pre-circulation embryos (Fig. 1F) . Finally, immunophenotypic EMPs were found exclusively in the yolk sacs of E9.5 Ncx1-null circulation-deficient embryos (Fig.  1G ). Comparable numbers of EMPs, normally distributed throughout the embryo, were concentrated in the yolk sac of Ncx1-null embryos (Fig. 1G ). This suggests that, unlike HSCs (North et al., 2009 ), EMP commitment is independent of blood flow. We conclude that EMPs emerge predominately, if not entirely, in the yolk sac.
EMP emergence is associated with markers of hemogenic endothelium and a subset of markers expressed by HSCs
HSCs co-express endothelial markers and hematopoietic markers as they emerge from hemogenic endothelium and the first definitive erythroid potential migrating into the yolk sac arises from a hemogenic endothelial precursor (Huber, 2004; Swiers et al., 2013 for review) . Likewise, E9.5 kit + CD41 + EMPs express multiple endothelial and hematopoietic markers (Fig. 1H) . Unlike HSCs, EMPs express CD16/32 but not Sca1 on their cell surface (Fig. 1H) or at the transcript level (data not shown). AA4.1, a marker of fetal liver HSCs (Petrenko et al., 1999) , is detected on a small proportion of E9.5 EMPs, but this may be part of EMP's endothelial marker expression. Unlike in the fetal liver, AA4.1 is expressed by E9.5 yolk sac endothelial cells (Ho et al., 2003) , and the majority of AA4.1 + cells in E9.5 yolk sacs are in the endothelial kit neg VE-Cadherin + population (88+/− 2% of AA4.1 + cells). Taken together, our data indicate that EMPs share markers of hemogenic endothelial emergence with HSCs, but can be distinguished by expression of CD16/32 and lack of Sca1 expression.
EMPs rapidly proliferate with extensive erythroid-myeloid potential
When E9.5 kit + CD41 + CD16/32 + cells were cultured in medium that supports diverse myeloid potential (Arinobu et al., 2005) , they proliferated more rapidly than bone marrow hematopoietic progenitors, increasing in number approximately 10,000 fold in 6 days ( Fig.  2A) . This proliferation was associated with rapid maturation, as evidenced by loss of CFC activity and a large increase in hemoglobin-containing erythroid cells as well as megakaryocytes and myeloid cells visible by four days in culture (Figs. 2B and 2C) . By seven days of culture, EMPs generated an extensive repertoire of cells with myeloid morphology (Fig. 2D ) that expressed lineage-specific genes (Fig. 2E) including macrophages, neutrophils, basophils, eosinophils, and mast cells. Interestingly, EMPs exhibited a significantly different lineage bias compared to bone marrow progenitors, and generated more erythroid than myeloid cells. Within the myeloid lineage, EMPs also produced a higher percentage of F4/80 + monocyte/macrophages, particularly large F4/80 hi macrophages, than GR-1 hi granulocytes (Fig. 2F, S1 ).
Individual EMPs can generate both erythroid and myeloid cells, as observed when E9.5 kit + CD41 + CD16/32 + cells plated in semi-solid media generated Emix colonies with erythroid and myeloid cells (Fig. 2G) . Furthermore, analysis of progeny from individual EMPs in liquid culture demonstrated that 17+/−4% EMPs had both erythroid and myeloid potential (Fig. 2H, S2 ). EMPs express many transcription factors that regulate hematopoietic lineage decisions in adults (Iwasaki et al., 2006; Orkin and Zon, 2008) and do so at levels intermediate between adult granulocyte-monocyte progenitors (GMPs) and megakaryocyteerythroid progenitors (MEPs), consistent with the observed erythroid and-myeloid potential of EMPs (Fig. 2I) . High levels of GATA-1 and low expression of Gfi1 compared with adult GMPs also correlates with the predilection of EMPs to generate erythroblasts and macrophages.
EMPs lack B cell potential B cell potential independent of HSC formation has been identified in the E9.5 yolk sac coincident with EMP formation (Kobayashi et al., 2014) . However, EMPs lack IL7R and Flt3 cell surface markers and Pax5 transcription factor expression, which are associated with lymphoid progenitors arising from HSCs (Fig. 1H , data not shown, Adolfsson et al., 2005) . Furthermore, EMPs differentiated in vitro in IL7-containing media failed to express Rag2, unlike parallel cultures of adult LK cells (Fig. 2E) . Primary purified EMPs cultured on an OP9 cell monolayer generated only myeloid and erythroid cells, while IL7R + bone marrow progenitors rapidly generated CD19 + B220 + cells ( Fig. 3A and B) . This short-term assay detects existing lymphoid progenitors, while extended cultures on OP9 stroma promotes emergence of lymphoid progenitors that then mature into B cells. As published (Yoshimoto et al., 2011) , extended cultures of unfractionated E9.5 yolk sac cells differentiated at a low frequency into lymphoid progenitors by 12 days in culture (Fig. 3D ), but when subfractionated B cell potential was present within the non-EMP fraction and absent in the EMP population, indicating that B cell potential emerges independently of EMPs in the E9.5 yolk sacs (Fig. 3C , D).
Differentiating embryonic stem (ES) cells recapitulate yolk sac hematopoiesis
Similar to the embryo, the first hematopoietic cells that emerge during differentiation of mouse or human ES cells are primitive erythroblasts with associated macrophages and megakaryocytes, including a primitive MEP (Fujimoto et al., 2003; Keller et al., 1993; Klimchenko et al., 2009; Paluru et al., 2014) . Definitive hematopoiesis subsequently emerges, but it remains unclear whether this represents the in vitro equivalent of HSC or EMP-derived definitive potential. We found that ES cells grown as embryoid bodies (EBs) generate a population of immunophenotypic EMPs coincident with the emergence of definitive CFCs (Fig. 4B) . Furthermore, definitive CFCs were predominately associated with the EMP fraction, while primitive erythroid CFCs did not reside in this population (Fig.  4C ). As seen in yolk sacs, macrophage potential of EBs was associated with both primitive and EMP hematopoiesis. We next asked whether B cell potential arises independently of EMP during ES/EB differentiation by comparing EB-derived immunophenotypic EMPs with the remainder of EB cells that were additionally VE-cadherin positive (Non-EMP VEC +) to enrich for possible B cell potential in this fraction (Yoshimoto et al., 2011) . As in the yolk sac, B cell potential was distinct from the sorted EMP fraction ( Fig. 4D and E). Thus, initial emergence of hematopoietic potential in ES/EBs appears to recapitulate the emergence of HSC-independent yolk sac hematopoiesis, consisting of a wave of primitive hematopoiesis followed by the emergence of distinct populations of EMP-definitive progenitors and a rarer population of cells with B cell potential.
EMPs migrate to the fetal liver and differentiate including production of neutrophils At E10.5, when the liver is colonized with hematopoietic progenitors, EMPs were found in most tissues at a similar ratio to primitive erythroid cells in the peripheral blood, indicating their widespread presence in the circulation (Fig. 5A ). EMPs remained enriched in the yolk sac above peripheral blood levels, as observed at E9.5, but were more highly enriched in the liver ( Fig. 1E and 5A ). This distribution of immunophenotypic EMPs mirrors that of functional CFCs in E10.5 embryos (Palis et al., 1999) . Additionally, the numbers of immunophenotypic EMPs and CFC in E10.5 blood and liver are similar and day 7 CFC activity was found predominately in sorted EMP (Fig. S3) . After E10.5, there is a diminution of circulating EMPs, consistent with their egress into the fetal liver, although low numbers of circulating EMPs are still detected through E14.5, suggesting they may continue to colonize the fetal liver even as HSCs expand there (Fig. 5B) .
We next asked whether the extensive in vitro myeloid potential of EMPs (Fig. 3D) is realized in the embryo. Wildtype females were mated to GFP + males (UBC-GFP) so the resultant GFP + fetal blood cells could be distinguished from any contaminating GFP − maternal cells. Rare embryonic granulocytes were detected in circulation as early as E11.5, and by E12.5, sorted GFP+ myeloid cells included those with neutrophil morphology (Figs. 5C, 5D and 5E). Myelopoiesis was evident in the fetal liver by E11.5, with megakaryocytes and macrophages comprising the majority of the non-erythroid hematopoietic cells (Fig. 5F ). While these lineage ratios are consistent with the in vitro potential of EMPs, early megakaryocytes and macrophages could also derive from primitive hematopoiesis. Thus, EMP myeloid fate is best confirmed by the emergence of granulopoiesis in the murine embryo. The fetal liver contained a similar range of granulocyte intermediates, as defined by GR-1 staining and cell size, present in the bone marrow (Figs. 5G and 5H), although with higher proportion of immature forms, as expected for onset and rapid expansion of granulopoiesis (Fig. 5I) . Circulating granulocytes had neutrophil morphology (Fig. 5D for example), which agrees with a lack of detectable transcripts in the early fetal liver for eosinophil peroxidase (Epx) or a shared surface marker of basophils and mast cells (FCεR) (Fig. 5J) . Additionally, consistent with a neutrophil identity, a significant oxidative burst in fetal GR-1+ cells was observed after stimulation with bacterial particles (Fig. 5K) . These data provide evidence that the broad granulocyte potential of EMP in vitro is refined in the early fetus to the output of functional neutrophils.
EMPs engraft adult recipients and transiently generate red blood cells with adult-like characteristics
As EMP potential temporally overlaps with that of adult repopulating HSCs or immature HSCs, (Frame et al. 2013 for review), we asked whether EMPs contain long-term hematopoietic potential using UBC-GFP mice as donors to detect of reconstitution of erythrocytes and platelets as well as myeloid and lymphoid cells (Schaefer et al., 2001 ). Long-term reconstitution was not found when E10.5 EMPs were transplanted into normal adult recipients or when E9.5 or E10.5 EMPs were transplanted into immunocompromised mice either by intravenous or by intrafemoral injection (Fig. 6A) . In contrast, E10.5 AGM or adult bone marrow cells provided long-term multilineage reconstitution. Therefore, like early B cell potential, EMPs are independent of early HSC potential in the embryo.
EMPs did, however, provide varying degrees of short-term reconstitution (Fig. 6A) . Transplanted EMPs rapidly created a wave of circulating RBCs which persisted for weeks in the adult (Fig. 6B, Fig. S4 ). Reconstitution was usually limited to the erythroid lineage, with only occasional small numbers of myeloid cells or platelets detected. In the fetus, EMPs generate larger RBCs that express gamma globin in embryos transgenic for the human beta-globin locus . Interestingly, in the reconstituted adult, EMP-derived RBCs were instead similar in size to adult RBCs (Fig. 6C and D) . Additionally, EMPs transgenic for the human beta-globin locus generated RBCs in the adult that expressed predominately adult beta-globin (Fig. 6E) . Thus, in the adult hematopoietic environment, EMPs retain their erythroid-biased short-term hematopoietic potential but generate mature erythrocytes with adult, rather than fetal, characteristics.
Discussion
The first blood cells in mammalian embryos consist of large nucleated "primitive" erythroid cells that arise from a transient wave of yolk sac progenitors. They are replaced in the fetus by smaller, enucleated red cells that were termed "definitive" more than a century ago (Maximov, 1909) . Fetal and postnatal definitive RBCs were assumed to comprise one continuous lineage derived from HSCs. While there is clear evidence that this two-wave model is an oversimplification, the legacy of this model and its nomenclature still influences many interpretations of hematopoietic emergence. Primitive hematopoiesis is not restricted to erythroid cells, but is associated with macrophage and megakaryocyte potential (Palis et al., 1999; Paluru et al., 2014; Tober et al., 2007; Hoeffel et al. 2015) . Our data have shown further that primitive and EMP-associated macrophage progenitors can be distinguished prospectively by immunophenotype. Consistent with a tri-lineage primitive hematopoietic potential, we and others have identified populations of maturing macrophages and megakaryocytes in the E9.5 yolk sac prior to formation of the fetal liver (Tober et al. 2007; Perdiguero et al. 2014; Hoeffel et al. 2015) . The expression of CD41 and CD45 on these cells complicates the use of these markers in the identification of co-emerging definitive hematopoietic progenitors.
It has also become clear that along with the primitive hematopoietic potential, definitive blood cells also arise independently of HSC. In both human and mouse embryos, the first definitive erythroid progenitors emerge in the yolk sac before HSC arise and colonize the fetal liver prior to HSC (Frame et al. 2013 for review). While kit and CD41 mark both EMP and HSC emergence (Bertrand et al., 2005; Ferkowicz et al., 2003; Mikkola et al., 2003; Mitjavila-Garcia et al., 2002) , we find that EMPs also become CD16/32 + , a triple-positive immunophenotype without corollary in the adult hematopoietic hierarchy (Miyawaki et al., 2014; Pronk et al., 2007 ). This phenotype made it possible to trace EMP emergence in the E8.5-9.5 yolk sac and their colonization of the fetal liver at E10.5-11.5. In contrast to the small numbers of adult transplantable and/or immature HSCs detected per embryo until E12.5, thousands of EMPs and hundreds of thousands of hematopoietic intermediates are detected during this time. These data complement lineage tracing experiments demonstrating yolk sac progenitors contribute significantly to fetal liver myelopoiesis (Perdiguero et al. 2014; Hoeffel et al. 2015) . While mouse embryos defective in HSC formation survive until birth, embryos with defects in primitive erythropoiesis die as early as E9.5, and those with defects in EMP-derived definitive erythropoiesis die by E15.5 (Chen et al., 2011; Fujiwara et al., 1996; Mucenski et al., 1991) . Thus, the yolk sac provides erythroid and myeloid function through two distinct waves of progenitors that sequentially support embryogenesis until HSC-derived hematopoiesis is established at later stages of gestation.
EMPs generate erythroid cells, megakaryocytes and a wide range of myeloid lineages in vitro. Our clonal analyses confirmed the presence of single EMPs with erythroid and myeloid potential, consistent with "common myeloid progenitors" (CMPs). However, there are important distinctions between EMPs and adult CMPs. In the adult, CD16/32 is expressed at low levels in CMPs and high levels in GMPs, which have lost erythroid and megakaryocyte potential (Akashi et al., 2000) . Furthermore, adult murine CMPs can be subfractionated into a CD150 + population with mainly MEP potential and a CD150 − population with mainly GMP potential (Pronk et al., 2007) . In contrast, EMPs express high levels of CD16/32 and lack CD150 expression, yet are still strongly biased to generate erythroid cells and megakaryocytes. In vitro, EMPs are also biased to produce more macrophages than granulocytes, while CMPs preferentially form granulocytes (Akashi et al., 2000) . These in vitro lineage biases are consistent with their expression profile of transcription factors known to control adult erythro-myeloid lineage choice. This suggests that EMPs not only make definitive, or adult-like, blood cells, but may share transcriptional regulators with adult hematopoiesis in altered proportions that generate a hematopoietic progenitor specifically designed to meet the needs of the rapidly growing embryo.
Primitive hematopoietic progenitors and EMPs each generate megakaryocytes and macrophages. It has recently been demonstrated that yolk sac progenitors are an important source of multiple tissue-resident macrophages in the adult. Both primitive and EMPderived macrophages have been traced to different adult tissues. (Kierdorf et al., 2013; Perdiguero et al., 2014; Schulz et al., 2012; Ginhoux et al. 2010; Hoeffel et al. 2015) . The first definitive erythroid and granulocyte potential in the mouse embryo are derived from EMPs and not from primitive hematopoiesis, and thus we used these lineages to specifically analyze EMP differentiation. Our previous studies demonstrated expanding definitive erythropoiesis in the fetal liver and the first definitive erythrocytes in the circulation by E11.5 . Similarly, we report here that fetal granulocytes are present in the liver and bloodstream by E11.5 and then expand rapidly in both compartments. Interestingly, the wider granulocytic potential of EMPs is apparently narrowed to a neutrophil fate in the early fetus. Although we do not yet know if neutrophils have a role in mammalian embryogenesis, fetal neutrophils exhibited antibacterial oxidation responses consistent with a role in host defense. There are also possible roles for neutrophils in angiogenesis and niche interactions as seen in the adult (Casanova-Acebes et al., 2014; Christoffersson et al., 2012) .
The emergence of lymphoid or long-term hematopoietic potential temporally overlaps with EMP emergence (Godin et al., 1995; Kieusseian et al., 2012; Kumaravelu et al., 2002; Yoder et al., 1997; Yoshimoto et al., 2011; Yoshimoto et al., 2012) . While it is unclear how these latter potentials relate to one another, they have characteristics distinct from EMPs. Both lymphoid and nascent HSC emergences are more broadly distributed and considerably more rare than EMPs. However, the overlap in markers and timing could indicate they comprise a subset of EMPs. Our analysis of purified populations of EMPs demonstrated that early lymphoid and HSC potential are indeed distinct at E9.5. Taken together, these data indicate that the emergence of hematopoiesis in the embryo is remarkably complex, with distinct hematopoietic populations that have varied spatio-temporal emergence, abundance, lineage potential and persistence. It is important to note that our studies have focused on the onset of hematopoiesis and prior to significant HSC expansion, so they do not rule out the possibility that hematopoietic progenitors continue to evolve in their phenotype or potential over time.
Ultimately, it will be important to determine how hematopoietic stem and progenitor cells with different lineage restrictions and self-renewal potential are generated in the developing embryo. ES and iPS cells are important experimental models of hematopoietic emergence with the promise of serving as a source of cell-based therapies. However, the absence of precise temporal and spatial cues makes it difficult to correlate findings in the ES/iPS system with those known to occur in the embryo. By comparing our observations in the embryo directly with those from differentiating ES cells, we found that ES cells recapitulated the hematopoietic development present in the yolk sac, including primitive hematopoietic, definitive EMP and rare B cell potential. This is not unexpected, given that these models mimic early embryogenesis and hematopoiesis generated from yolk sac progenitors account for almost all of the blood cells seen in the murine embryo from E7.5 to E12.5. The ability to identify and track yolk sac-derived hematopoietic lineages should facilitate future studies directing the development of ES/iPS cell systems beyond the yolk sac phase of hematopoietic emergence toward the formation of HSCs. Additionally, given their potential to provide short-term definitive erythrocytes, platelets and granulocytes, EMPs might also serve therapeutic roles. A better understanding of EMP will be critical to increase the cellular output and compatibility with the adult hematopoietic microenvironment.
Experimental Procedures

Mice, Tissue Collection and Processing
Mice were used in accordance with the guidelines of the University of Rochester School of Medicine and Dentistry Institutional Animal Care and Use Committee. Mice were maintained on 12-hour dark and light cycles. See supplemental experimental information for strains used. Mice were mated overnight and vaginal plugs examined in the morning (E0.3). Mice were sacrificed by CO 2 narcosis. Embryonic tissues were isolated from staged embryos and dissociated as previously described . Adult peripheral blood was collected from a tail or submandibular vein for analysis of reconstitution or was collected from the descending vena cava for terminal analysis. Femoral marrow was flushed and dissociated by trituration. For transplantation, cells were either injected in the tail vein or intrafemorally (Schmitz et al., 2011) into recipients pre-conditioned with 5Gy TBI for C57B6 and 1.5Gy TBI for NSG mice.
In Vitro Cultures
Colony forming assays for megakaryocyte progenitors, erythroid and myeloid progenitors and high proliferative potential progenitors were performed as previously described (Palis et al., 2001; Palis and Koniski, 2005) . Embryonic tissues were explanted with two embryo equivalents in 100 ul of media as described (Shah et al., 2013) . Sorted cells were cultured in maturation media (Arinobu et al., 2005) containing 20 ng/ml murine stem cell factor, IL-3, IL-6, and IL-7; 50 ng/ml IL-5 and IL-9; 10 ng/ml IL-11, granulocyte-macrophage colony-stimulating factor and thrombopoietin, (all Peprotech), and 2 U/ml erythropoietin (Amgen) at 10 5 cells/ml or less. Short-term and long-term assays of B cell progenitors were performed as described (Yoshimoto et al., 2011) .
ES/EB cells
PC13 embryonic stem cells (University of Rochester Transgenic Facility) and W4 cell lines (developed in the laboratory of Dr. Alex Joyner at NYU School of medicine) were cultured as EBs essentially as described (England et al., 2011) except that EBs were dissociated using collagenase type 1 according to manufacturer's instructions (Stemcell Technologies).
Cell staining and microscopy
Cytospun cells were stained using an automated Wright stain (Sigma) as described (Kingsley et al., 2004) or stained with standard Hematoxylin and Eosin (H&E) or acetylcholinesterase (ACE). Photomicroscopy was performed on a Nikon Eclipse 80i microscope using a 100X objective or for colonies a Nikon TE2000 and a 20x objective. Images were captured with a Nikon DS-Fi1 camera and minimally processed using Nikon Elements AR or Photoshop software.
PCR
For RT-PCR, RNA was extracted using RNeasy Plus Mini Kits (Qiagen), and cDNA synthesized utilizing SuperScript First-Strand Synthesis Systems (Invitrogen) according to manufacture's instructions. For quantitative RT-PCR, cDNA was made from sorted cells using the Cells to CT kit according to manufacturer's instructions (ABI). Primers and conditions are contained in supplemental experimental information. Expression levels were normalized to 18S transcript levels.
Flow Cytometry and Cell Sorting
Cells were blocked with 10% normal rat serum (Invitrogen) and then stained as indicated in experimental supplementary information with 1:100 dilutions of antibodies, vital DNA stain (10 uM DRAQ5 (eBioscience), or Vibrant Violet as recommended (Invitrogen) and live/ dead discriminator (1 ug/ml propidium iodide or 5 ug/ml DAPI: Invitrogen). Engraftment of RBC and platelets was assayed using 2 ul of whole blood and engraftment of myeloid cells was determined using 50 ul of blood analyzed after RBC lysis. Oxidative burst assay was performed after stimulation of cells with S. aureus bioparticles (Lifetechnologies) and detected utilizing dihydroethidium (DHE: Sigma) as reported (McFarlin et al., 2013) . Cells were sorted using a FACS Aria or analyzed on an LSRII (BD Bioscience) using FlowJo analysis software (Treestar). Imaging flow cytometric data were collected on a ImageStreamX and analyzed using IDEAS 6.0 (Amnis). 
